What are the symptoms and typical age of onset for choroidal melanoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Choroidal Melanoma: Symptoms and Age of Onset

Choroidal melanoma typically presents with symptoms including blurry vision, progressive visual field loss, photopsia (flashes of light), and floaters, with onset most commonly occurring in the sixth decade of life and increasing in incidence with age. 1

Clinical Presentation

Common Symptoms

  • Blurry vision
  • Progressive visual field loss
  • Photopsia (flashes of light)
  • Floaters 1
  • Gradual diminution of vision 2
  • Headache 2

Less Common Symptoms

  • Visual distortion
  • Visual spots
  • Pain (usually in advanced cases)

Important Note

Many patients with choroidal melanoma may be asymptomatic, with the tumor being discovered during routine fundus examination. This makes regular eye examinations crucial for early detection. 3

Age of Onset

  • Most commonly occurs from the sixth decade of life (60+ years) 2
  • Incidence increases progressively with age 2
  • Global incidence is approximately 20 per million cases per year 2

Clinical Features and Diagnostic Findings

Choroidal melanoma can be identified by several characteristic features:

  • Hyperpigmented (sometimes amelanotic) and elevated choroidal mass on fundoscopy 3
  • Low internal reflectivity on ultrasonography 3
  • Solid choroidal mass on OCT 3
  • Multiple areas of pinpoint leakage on fluorescein angiography 3
  • Blockage of fluorescence on indocyanine green angiography (ICGA) 3

Risk Factors for Growth and Malignancy (TFSOM)

The mnemonic TFSOM (To Find Small Ocular Melanoma) helps differentiate small choroidal melanoma from benign choroidal nevus: 4

  • T: Thickness >2 mm
  • F: Subretinal Fluid
  • S: Symptoms (as listed above)
  • O: Orange pigment
  • M: Margin touching optic disc

Tumors displaying:

  • 0 factors: 3% chance for growth at 5 years (likely benign nevus)
  • 1 factor: 38% chance for growth
  • 2+ factors: >50% chance for growth (likely small choroidal melanoma) 4

Prognosis Based on Size

Metastasis rates at 5 years based on tumor size: 4

  • Small choroidal melanoma (<4 mm thickness): 16%
  • Medium choroidal melanoma (4-8 mm thickness): 32%
  • Large choroidal melanoma (>8 mm thickness): 53%

Differential Diagnosis

Choroidal melanoma must be differentiated from:

  • Choroidal nevus
  • Choroidal metastases (yellow-white elevated lesions, sometimes multifocal) 3
  • Circumscribed cavernous choroidal hemangioma 3
  • Choroidal osteoma 3
  • Hematological malignancies affecting the choroid 3

Clinical Pitfalls and Caveats

  1. Early choroidal melanomas can be mistaken for benign choroidal nevi, delaying diagnosis and treatment.
  2. The presence of even one risk factor from the TFSOM criteria warrants close monitoring.
  3. Asymptomatic presentation is common, emphasizing the importance of routine fundus examination.
  4. Despite treatment, approximately 50% of choroidal melanoma patients develop metastases, highlighting the importance of early detection and treatment. 1

Early detection and treatment of choroidal melanoma are critical for improving patient prognosis, as smaller tumors have significantly better outcomes regarding metastasis risk.

References

Research

Choroidal Melanoma: A Mini Review.

Medicines (Basel, Switzerland), 2023

Research

Choroid Melanoma - A Rare Case Report.

Journal of clinical and diagnostic research : JCDR, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical features of small choroidal melanoma.

Current opinion in ophthalmology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.